247 related articles for article (PubMed ID: 29468422)
1. Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.
Sugai T; Eizuka M; Arakawa N; Osakabe M; Habano W; Fujita Y; Yamamoto E; Yamano H; Endoh M; Matsumoto T; Suzuki H
Gastric Cancer; 2018 Sep; 21(5):765-775. PubMed ID: 29468422
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers.
Sugai T; Takahashi Y; Eizuka M; Sugimoto R; Fujita Y; Habano W; Otsuka K; Sasaki A; Yamamoto E; Matsumoto T; Suzuki H
Mol Carcinog; 2018 Mar; 57(3):451-461. PubMed ID: 29230882
[TBL] [Abstract][Full Text] [Related]
3. A genome-wide study of gastric intramucosal neoplasia based on somatic copy number alterations, gene mutations, and mRNA expression patterns.
Koike Y; Osakabe M; Sugimoto R; Uesugi N; Matsumoto T; Suzuki H; Yanagawa N; Sugai T
J Pathol Clin Res; 2024 Mar; 10(2):e12368. PubMed ID: 38454538
[TBL] [Abstract][Full Text] [Related]
4. Genetic differences stratified by PCR-based microsatellite analysis in gastric intramucosal neoplasia.
Sugai T; Sugimoto R; Habano W; Endoh M; Eizuka M; Tsuchida K; Yamamoto E; Kawasaki K; Yanai S; Matsumoto T; Suzuki H
Gastric Cancer; 2017 Mar; 20(2):286-296. PubMed ID: 27236438
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers.
Sugai T; Eizuka M; Habano W; Fujita Y; Sato A; Sugimoto R; Otsuka K; Yamamoto E; Matsumoto T; Suzuki H
Oncotarget; 2018 May; 9(33):22895-22906. PubMed ID: 29796160
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtypes of colorectal cancers determined by PCR-based analysis.
Sugai T; Eizuka M; Takahashi Y; Fukagawa T; Habano W; Yamamoto E; Akasaka R; Otuska K; Matsumoto T; Suzuki H
Cancer Sci; 2017 Mar; 108(3):427-434. PubMed ID: 28083970
[TBL] [Abstract][Full Text] [Related]
7. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
8. Association between genomic alterations and metastatic behavior of colorectal cancer identified by array-based comparative genomic hybridization.
Sawada T; Yamamoto E; Suzuki H; Nojima M; Maruyama R; Shioi Y; Akasaka R; Kamimae S; Harada T; Ashida M; Kai M; Adachi Y; Yamamoto H; Imai K; Toyota M; Itoh F; Sugai T
Genes Chromosomes Cancer; 2013 Feb; 52(2):140-9. PubMed ID: 23073979
[TBL] [Abstract][Full Text] [Related]
9. Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
Mizuguchi A; Takai A; Shimizu T; Matsumoto T; Kumagai K; Miyamoto S; Seno H; Marusawa H
Int J Cancer; 2018 Oct; 143(8):1923-1934. PubMed ID: 29717480
[TBL] [Abstract][Full Text] [Related]
10. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract][Full Text] [Related]
11. Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
Takahashi Y; Sugai T; Habano W; Ishida K; Eizuka M; Otsuka K; Sasaki A; Takayuki Matsumoto ; Morikawa T; Unno M; Suzuki H
Int J Cancer; 2016 Dec; 139(11):2493-501. PubMed ID: 27509333
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
14. p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers.
Bond CE; Umapathy A; Ramsnes I; Greco SA; Zhen Zhao Z; Mallitt KA; Buttenshaw RL; Montgomery GW; Leggett BA; Whitehall VL
Int J Cancer; 2012 Apr; 130(7):1567-76. PubMed ID: 21557216
[TBL] [Abstract][Full Text] [Related]
15. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
16. Chr20q Amplification Defines a Distinct Molecular Subtype of Microsatellite Stable Colorectal Cancer.
Zhang B; Yao K; Zhou E; Zhang L; Cheng C
Cancer Res; 2021 Apr; 81(8):1977-1987. PubMed ID: 33619118
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F
Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma.
Uesugi N; Sugai T; Sugimoto R; Eizuka M; Fujita Y; Sato A; Osakabe M; Ishida K; Koeda K; Sasaki A; Matsumoto T
Pathology; 2017 Oct; 49(6):596-603. PubMed ID: 28830689
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
